Fast Five Quiz: Exudative (Wet) Age-Related Macular Degeneration Management

F. Ryan Prall, MD


November 05, 2020

Exudative (wet) age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly population. Recent advances in treatments can help slow the progression of wet AMD; however, there is currently no cure for this debilitating condition, and treatment adherence can be poor.

The current armamentarium for wet AMD includes anti–vascular endothelial growth factor (VEGF) injections, photodynamic therapy (PDT), and combination treatment. An extensive pipeline of new therapeutics for wet AMD is expected to extend the dosing interval beyond that of currently available agents. The treatment landscape in wet AMD will become much more complex over the next few years, with the potential for improved responses to treatment.

How much do you know about the management of wet AMD? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.